Zhang, Y., Xiong, W., Qian, J., Duan, R., Guo, Q., Wang, Q., Wu, W., Zhang, C., Li, Y., Xian, M., Lu, Y., Esnaola, N. F., Chang, J. C., Xiao, L., Zhong, L., Yi, Q. (2026). T cells engineered against Dickkopf-1-A2 complex can be used to treat HLA-A2+ solid and hematologic cancers. Nature Communications. https://doi.org/10.1038/s41467-026-69621-8